Invention Grant
- Patent Title: Heterocyclic compounds for the inhibition of PASK
- Patent Title (中): 用于抑制PASK的杂环化合物
-
Application No.: US13408893Application Date: 2012-02-29
-
Publication No.: US08916560B2Publication Date: 2014-12-23
- Inventor: John M. McCall , John McKearn , Donna L. Romero , Michael Clare
- Applicant: John M. McCall , John McKearn , Donna L. Romero , Michael Clare
- Applicant Address: US CA San Francisco
- Assignee: BioEnergenix, LLC
- Current Assignee: BioEnergenix, LLC
- Current Assignee Address: US CA San Francisco
- Agent Dennis A. Bennett; Brock Levin
- Main IPC: A61K31/50
- IPC: A61K31/50 ; A61K31/495 ; C07D241/36 ; C07D241/54 ; A61K45/06 ; C07D401/04 ; C07D401/12 ; C07D403/04 ; C07D405/04 ; C07D409/04
Abstract:
Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.
Public/Granted literature
- US20120165318A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK Public/Granted day:2012-06-28
Information query
